The effect of metformin on mean platelet volume in diabetic patients

Platelets

Volumn 24, Issue 2, 2013, Pages 118-121

  Dolasik, Ilhan ^a   Sener, Selcuk Y ^a   Celebi, Koray ^a   Aydin, Zeki M ^a   Korkmaz, Ugur ^a   Canturk, Zeynep ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Diabetes mellitus; Mean platelet volume; Metformin; Platelet

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN PLATELET VOLUME; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SMOKING; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PLATELET COUNT;

EID: 84873395133     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.674165     Document Type: Article

References (21)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: Framingham Study. JAMA 1979;241:2035-2038 (Pubitemid 9228506)
2. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith Jr SC, Sowers Jr. Diabetes and cardiovascular disease: A statement for health care professionals from American Heart Association. Circulation 1999; 100:1134-1146 (Pubitemid 29416243)
3. Kristensen SD. The platelet-Vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis. Dan Med Bull 1992; 39(2):110-127
4. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399-404 (Pubitemid 34451156)
5. Valkila EH, Salenius JP, Koivula TA. Platelet indices in patients with occlusive carotid artery disease. Angiology 1994; 45(5):361-365 (Pubitemid 24142664)
6. Grove EL, Orntoft TF, Lassen JF, Jensen HK, Kristensen SD. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med 2004;255(6):637-644 (Pubitemid 38703582)
7. Bath PM, Carney C, Markandu ND, MacGregor GA. Platelet volume is not increased in essential hypertension. J Hum Hypertens 1994;8(6):457-459 (Pubitemid 24195761)
8. Dow RB. The clinical and laboratory utility of platelet volume parameters. Aust J Med Sci 1994;15:12-15
9. Bancroft AJ, Abel EW, Mclaren M, Belch JJ. Mean platelet volume is a useful parameter: A reproducible routine method using a modified Coulter thrombocytometer. Platelets 2000; 11:379-387
10. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17:67-69 (Pubitemid 41759244)
11. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865
12. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Ryden L, DIGAMI 2 Investigators. The impact of glucose lowering treatment on long-Term prognosis in patients with type 2 diabetes and myocardial infarction: A report from the DIGAMI 2 trial. Eur Heart J 2008;29:166-176
13. De JJ, Kooy A, Lehert P, Bets D, Wulffele MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD. Effects of short-Term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: A randomized, placebo-Controlled trial. J Intern Med 2005;257:100-109 (Pubitemid 40129131)
14. ADA Clinical Practice Recommendations. Standards of medical care. Diabetes Care 2009;32(Suppl. 1):13-61
15. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Trombosit size as a deteminant of trombosit function. J Lab Clin Med 1983;101:205-213
16. Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002;13:301-306 (Pubitemid 34864514)
17. Mathur A, Robinson MS, Cotton J, Martin JF, Erusalimsky JD. Platelet reactivity in acute coronary syndrome: Evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost 2001;85:989-994 (Pubitemid 32573748)
18. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117(2): 399-404 (Pubitemid 34451156)
19. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammatioñCurr Pharm Des 2011;17(1):47-58
20. Mylotte D, Kavanagh GF, Peace AJ, Tedesco AF, Carmody D, O'reilly M, Foley DP, Thompson CJ, Agha A, Smith D, Kenny D. Platelet reactivity in type 2 diabetes mellitus: A comparative analysis with survivors of myocardial infarction and the role of glycaemic control. Platelets. 2011 Dec 13. Doi:10.3109/09537104.2011.634932 [Epub ahead of print].
21. Unubol M, Ayhan M, Guney E. The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus. Platelets. 2011 Nov 29. Doi:10.3109/09537104.2011.634934 [Epub ahead of print].